Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
JACC Cardiovasc Imaging. 2011 May;4(5):523-33. doi: 10.1016/j.jcmg.2011.03.010.
To evaluate the relationship between serial cardiac troponin T (cTnT) levels with infarct size and left ventricular ejection fraction by gated single-photon emission computed tomography myocardial perfusion imaging (SPECT-MPI) in patients with acute myocardial infarction (AMI).
Current guidelines recommend the use of cTnT as the biomarker of choice for the diagnosis of AMI. Data relating cTnT to SPECT-MPI in patients with AMI are limited.
A subset of patients with their first AMI participating in a community-based cohort of AMI in Olmsted County, Minnesota, were prospectively studied. Serial cTnT levels were evaluated at presentation, <12 h and 1, 2, and 3 days after onset of pain. Peak cTnT was defined as the maximum cTnT value.
A total of 121 patients (age, 61 ± 13 years; 31% women) with AMI underwent gated SPECT-MPI at a median (25th percentile, 75th percentile) of 10 (5, 15) days post-AMI. The type of infarct was non-ST-segment elevation myocardial infarction in 61%, and 13% were anterior in location. The median infarct size was 1% (0%, 11%) and the median gated left ventricular ejection fraction was 54% (47%, 60%). Fifty-nine patients (49% of the population) had no measurable infarction by SPECT-MPI. Independent predictors of measurable SPECT-MPI infarct size included cTnT at days 1, 2, and 3 and peak cTnT, but not at presentation or <12 h. In receiver-operator characteristic analysis, the area under the curve was highest at day 3. Receiver-operator characteristic analysis demonstrated a cutoff of 1.5 ng/ml for peak cTnT for the detection of measurable infarct size.
In a community-based cohort of patients with their first AMI, independent predictors of measurable SPECT-MPI infarct size included cTnT at days 1, 2, and 3 and peak cTnT. In contrast, cTnT level at presentation and <12 h was not an independent predictor of myocardial infarction size as assessed by SPECT-MPI. Receiver-operator characteristic analysis demonstrated a cutoff value peak cTnT of 1.5 ng/ml for the detection of measurable infarct.
通过门控单光子发射型计算机断层心肌灌注成像(SPECT-MPI)评估急性心肌梗死(AMI)患者连续心肌肌钙蛋白 T(cTnT)水平与梗死面积和左心室射血分数的关系。
目前的指南建议使用 cTnT 作为 AMI 诊断的首选生物标志物。与 AMI 患者的 SPECT-MPI 相关的数据有限。
前瞻性研究明尼苏达州奥姆斯特德县社区性 AMI 队列中首次发生 AMI 的部分患者。在发病后即刻、<12 小时以及 1、2 和 3 天时评估连续 cTnT 水平。峰值 cTnT 定义为最大 cTnT 值。
共有 121 例 AMI 患者(年龄 61±13 岁;31%为女性)在 AMI 后中位(25%分位数,75%分位数)10(5,15)天时接受了门控 SPECT-MPI。梗死类型为非 ST 段抬高型心肌梗死占 61%,13%为前壁。中位梗死面积为 1%(0%,11%),中位门控左心室射血分数为 54%(47%,60%)。59 例(人群的 49%)患者 SPECT-MPI 未见可测量的梗死。可测量 SPECT-MPI 梗死面积的独立预测因素包括 cTnT 在第 1、2 和 3 天以及峰值 cTnT,但在发病时或<12 小时时无预测作用。在受试者工作特征曲线分析中,曲线下面积在第 3 天最高。受试者工作特征曲线分析显示,峰值 cTnT 的截断值为 1.5ng/ml,用于检测可测量的梗死面积。
在社区性首次 AMI 患者队列中,可测量 SPECT-MPI 梗死面积的独立预测因素包括 cTnT 在第 1、2 和 3 天以及峰值 cTnT。相比之下,cTnT 水平在发病时和<12 小时时并不是 SPECT-MPI 评估的心肌梗死面积的独立预测因素。受试者工作特征曲线分析显示,峰值 cTnT 的截断值为 1.5ng/ml,用于检测可测量的梗死。